---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-041168"
form_type: "8-K"
ticker: "GRTX"
cik: "0001563577"
company_name: "Galera Therapeutics, Inc."
filed_at: "2023-02-16T23:59:59+00:00"
generated_at: "2026-06-19T09:24:25.781023+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Galera raises $30M in registered direct offering of stock and warrants

## Summary
- Offering of 14,320,000 shares at $2.095/share plus warrants to buy 14,320,000 shares at $1.97.
- Gross proceeds of $30M; net to fund avasopasem pre-commercialization, rucosopasem development, and working capital.
- Closing expected February 17, 2023; 90-day lock-up for officers and directors.
- Piper Sandler acted as sole placement agent; 6% placement fee on gross proceeds.

## SEC filing metadata
- accession: 0001193125-23-041168
- form_type: 8-K
- ticker: GRTX
- cik: 0001563577
- company_name: Galera Therapeutics, Inc.
- filed_at: 2023-02-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563577/000119312523041168/0001193125-23-041168-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563577/000119312523041168/d424770d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-041168
- JSON: https://secwatch.observer/filing/0001193125-23-041168.json
- Plain text: https://secwatch.observer/filing/0001193125-23-041168.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.